perimenopause and glp 1 GLP-1 Microdosing for Perimenopause: Benefits & Risks Weight Loss During Perimenopause: Rooted
Description
R.van Herk-SukelM
In the intestine, GLP-1 production colocalizes with the production of glucose-dependent insulinotropic polypeptide (GIP) or peptide YY (PYY), and they share physiological properties, such as glucose control (Holst, 2007)
How GLP-1 Medications Can Help Manage PCOS Symptoms Polycystic Ovary Syndrome (PCOS) affects 1 in 10 women in the UK, making it one of the most common hormonal disorders among women of reproductive age
Age-specific timeline example (38-year-old woman): A compressed approach might look like this: spend months 0-4 on GLP-1 treatment, then months 4-6 in the washout period (2 months), and by month 6 begin trying or proceed to IVF
